Therapeutics
Search By Attributes
Search Results
| Name | Synonyms | FDA Status | Company | Target Type | Therapy Type | Approved For |
|---|---|---|---|---|---|---|
| ACP-204 | Alzheimer's Disease (Phase 2/3) | Acadia Pharmaceuticals | Other Neurotransmitters | Small Molecule | ||
| AXS-05 | Dextromethorphan/bupropion, Auvelity |
Alzheimer's Disease (Phase 2/3) | Axsome Therapeutics, Inc. | Other Neurotransmitters | Combination, Small Molecule | Major depressive disorder |
| Blarcamesine | Anavex 2-73 | Alzheimer's Disease (Phase 2/3), Parkinson's Disease Dementia (Phase 2), Parkinson's Disease (Phase 1) | Anavex Life Science Corp. | Other | Small Molecule | |
| Buntanetap | Posiphen, ANVS-401, Posiphen tartrate |
Alzheimer's Disease (Phase 2/3), Parkinson's Disease (Phase 3) | Annovis Bio | Amyloid-Related, alpha-synuclein | Small Molecule | |
| Metformin | Glucophage, Glucophage XR |
Alzheimer's Disease (Phase 2/3) | Other | Small Molecule | Type 2 Diabetes | |
| Vascepa | Icosapent ethyl (IPE), Ethyl eicosapentaenoic acid (E-EPA), AMR101, Miraxion |
Alzheimer's Disease (Phase 2/3) | Other | Small Molecule | Severe hypertriglyceridemia, and to lower risk of cardiovascular events in people with elevated triglycerides |